Elise Chong, MD

Articles by Elise Chong, MD

Assessing the Durability and Toxicity of CAR T-Cell Therapy in DLBCL

January 17th 2020

Elise Chong, MD, discusses the rationale for conducting a 4-year analysis of tisagenlecleucel in patients with relapsed/refractory diffuse large B-cell lymphoma.

Latest Updated Articles

Assessing the Durability and Toxicity of CAR T-Cell Therapy in DLBCL
January 17th 2020